John Crowley
2019
In 2019, John Crowley earned a total compensation of $849.9K as Chief Financial Officer at Fusion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $109,069 |
|---|---|
| Option Awards | $425,718 |
| Salary | $310,500 |
| Other | $4,650 |
| Total | $849,937 |
Crowley received $425.7K in option awards, accounting for 50% of the total pay in 2019.
Crowley also received $109.1K in non-equity incentive plan, $310.5K in salary and $4.7K in other compensation.
Rankings
In 2019, John Crowley's compensation ranked 9,981st out of 13,971 executives tracked by ExecPay. In other words, Crowley earned more than 28.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,981 out of 13,971 | 29th |
Division Manufacturing | 4,034 out of 5,701 | 29th |
Major group Chemicals And Allied Products | 1,533 out of 2,200 | 30th |
Industry group Drugs | 1,311 out of 1,886 | 31st |
Industry Biological Products, Except Diagnostic Substances | 290 out of 389 | 25th |
Source: SEC filing on April 27, 2021.
Crowley's colleagues
We found two more compensation records of executives who worked with John Crowley at Fusion Pharmaceuticals in 2019.